114 related articles for article (PubMed ID: 27353978)
1. Histological Effect of Methotrexate and Folinic Acid on Oral Epithelium of Albino Rats.
Ahmad A; Kazi MS
J Coll Physicians Surg Pak; 2016 Jun; 26(6):455-8. PubMed ID: 27353978
[TBL] [Abstract][Full Text] [Related]
2. Challenging the clinical relevance of folinic acid over rescue after high dose methotrexate (HDMTX).
Cohen IJ
Med Hypotheses; 2013 Nov; 81(5):942-7. PubMed ID: 24035689
[TBL] [Abstract][Full Text] [Related]
3. Neurotoxicity after high-dose methotrexate (MTX) is adequately explained by insufficient folinic acid rescue.
Cohen IJ
Cancer Chemother Pharmacol; 2017 Jun; 79(6):1057-1065. PubMed ID: 28455583
[TBL] [Abstract][Full Text] [Related]
4. Biochemical modulation of fluorouracil: comparison of methotrexate, folinic acid, and fluorouracil versus folinic acid and fluorouracil in advanced colorectal cancer: a randomized trial.
Polyzos A; Tsavaris N; Giannopoulos A; Bacoyiannis C; Papadimas V; Kalahanis N; Karatzas G; Kosmas C; Sakelaropoulos N; Archimandritis A; Papachristodoulou A; Kosmidis P
Cancer Chemother Pharmacol; 1996; 38(3):292-7. PubMed ID: 8646806
[TBL] [Abstract][Full Text] [Related]
5. Weekly methotrexate (50mg/m(2)) without dose escalation as a primary regimen for low-risk gestational trophoblastic neoplasia.
Kang WD; Choi HS; Kim SM
Gynecol Oncol; 2010 Jun; 117(3):477-80. PubMed ID: 20347479
[TBL] [Abstract][Full Text] [Related]
6. The correlation between dose of folinic acid and neurotoxicity in children and adolescents treated for osteosarcoma with high-dose methotrexate (HDMTX): a neuropsychological and psychosocial study.
Bonda-Shkedi E; Arush MW; Kaplinsky C; Ash S; Goshen Y; Yaniv I; Cohen IJ
J Pediatr Hematol Oncol; 2013 May; 35(4):271-5. PubMed ID: 23612378
[TBL] [Abstract][Full Text] [Related]
7. α-Lipoic acid ameliorates oral mucositis and oxidative stress induced by methotrexate in rats. Histological and immunohistochemical study.
Ahmed AA; Selim MA; El-Sayed NM
Life Sci; 2017 Feb; 171():51-59. PubMed ID: 28062278
[TBL] [Abstract][Full Text] [Related]
8. Damaging effects of chronic low-dose methotrexate usage on primary bone formation in young rats and potential protective effects of folinic acid supplementary treatment.
Fan C; Cool JC; Scherer MA; Foster BK; Shandala T; Tapp H; Xian CJ
Bone; 2009 Jan; 44(1):61-70. PubMed ID: 18976724
[TBL] [Abstract][Full Text] [Related]
9. Effect of methotrexate and folinic acid on skeletal growth in mice.
Iqbal MP; Ahmed M; Umer M; Mehboobali N; Qureshi AA
Acta Paediatr; 2003 Dec; 92(12):1438-44. PubMed ID: 14971796
[TBL] [Abstract][Full Text] [Related]
10. The Memorial Sloan Kettering Cancer Center experience with outpatient administration of high dose methotrexate with leucovorin rescue.
Zelcer S; Kellick M; Wexler LH; Gorlick R; Meyers PA
Pediatr Blood Cancer; 2008 Jun; 50(6):1176-80. PubMed ID: 18266225
[TBL] [Abstract][Full Text] [Related]
11. Folinic acid protects against suppression of growth by methotrexate in mice.
Iqbal MP; Sultana F; Mehboobali N; Pervez S
Biopharm Drug Dispos; 2001 May; 22(4):169-78. PubMed ID: 11745919
[TBL] [Abstract][Full Text] [Related]
12. Demyelination and single-carbon transfer pathway metabolites during the treatment of acute lymphoblastic leukemia: CSF studies.
Surtees R; Clelland J; Hann I
J Clin Oncol; 1998 Apr; 16(4):1505-11. PubMed ID: 9552059
[TBL] [Abstract][Full Text] [Related]
13. Sequential use of hemoperfusion and single-pass albumin dialysis can safely reverse methotrexate nephrotoxicity.
Chan WK; Hui WF
Pediatr Nephrol; 2016 Oct; 31(10):1699-703. PubMed ID: 27335061
[TBL] [Abstract][Full Text] [Related]
14. High-dose methotrexate therapy of childhood acute lymphoblastic leukemia: lack of relation between serum methotrexate concentration and creatinine clearance.
Joannon P; Oviedo I; Campbell M; Tordecilla J
Pediatr Blood Cancer; 2004 Jul; 43(1):17-22. PubMed ID: 15170885
[TBL] [Abstract][Full Text] [Related]
15. Fish oil in comparison to folinic acid for protection against adverse effects of methotrexate chemotherapy on bone.
Raghu Nadhanan R; Fan CM; Su YW; Howe PR; Xian CJ
J Orthop Res; 2014 Apr; 32(4):587-96. PubMed ID: 24346859
[TBL] [Abstract][Full Text] [Related]
16. High-dose methotrexate and/or leucovorin rescue for the treatment of children with lymphoblastic malignancies: do we really know why, when and how?
Sterba J; Valík D; Bajciová V; Kadlecová V; Gregorová V; Mendelová D
Neoplasma; 2005; 52(6):456-63. PubMed ID: 16284689
[TBL] [Abstract][Full Text] [Related]
17. Influence of post-methotrexate folinic acid rescue on regimen-related toxicity and graft-versus-host disease after allogeneic bone marrow transplantation.
Nevill TJ; Tirgan MH; Deeg HJ; Klingemann HG; Reece DE; Shepherd JD; Barnett MJ; Phillips GL
Bone Marrow Transplant; 1992 May; 9(5):349-54. PubMed ID: 1617319
[TBL] [Abstract][Full Text] [Related]
18. [The effects of interleukin-11 on high-dose methotrexate (HDMTX) induced mucositis in Wistar rats].
Han YQ; Chen LJ; Sun XJ; Zhao GF; Cheng XY
Zhonghua Xue Ye Xue Za Zhi; 2004 Dec; 25(12):740-4. PubMed ID: 15730719
[TBL] [Abstract][Full Text] [Related]
19. Accumulation of methotrexate polyglutamates in lymphoblasts is a determinant of antileukemic effects in vivo. A rationale for high-dose methotrexate.
Masson E; Relling MV; Synold TW; Liu Q; Schuetz JD; Sandlund JT; Pui CH; Evans WE
J Clin Invest; 1996 Jan; 97(1):73-80. PubMed ID: 8550853
[TBL] [Abstract][Full Text] [Related]
20. Phase I trial of paclitaxel, carboplatin, and methotrexate with granulocyte colony-stimulating factor and leucovorin in advanced transitional cell carcinoma.
Edelman MJ; Meyers FJ; Houston J; Lauder I
Semin Oncol; 1997 Oct; 24(5 Suppl 15):S15-68-S15-71. PubMed ID: 9346226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]